glutamic acid and Carcinoma, Lobular

glutamic acid has been researched along with Carcinoma, Lobular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cavalli, LR; Fu, X; Grasso, CS; Győrffy, B; Heckler, MM; Klimach, U; Lewis, JA; Li, Z; Mahajan, A; Quist, MJ; Riggins, RB; Stires, H; Zwart, A	1

Other Studies

1 other study(ies) available for glutamic acid and Carcinoma, Lobular

Article	Year
Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities. Molecular and cellular endocrinology, 2018, 08-15, Volume: 471 Topics: Breast Neoplasms; Carcinoma, Lobular; Cell Line, Tumor; Drug Resistance, Neoplasm; Exome Sequencing; Female; Gene Amplification; Gene Expression Regulation, Neoplastic; Glutamic Acid; Hepatocyte Nuclear Factor 3-alpha; Humans; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Mutation; Protein Kinase Inhibitors; Receptors, Estrogen; Receptors, Metabotropic Glutamate; Signal Transduction; Tamoxifen; Transcriptome	2018

Article

Year

Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities.

Molecular and cellular endocrinology, 2018, 08-15, Volume: 471

Topics: Breast Neoplasms; Carcinoma, Lobular; Cell Line, Tumor; Drug Resistance, Neoplasm; Exome Sequencing; Female; Gene Amplification; Gene Expression Regulation, Neoplastic; Glutamic Acid; Hepatocyte Nuclear Factor 3-alpha; Humans; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Mutation; Protein Kinase Inhibitors; Receptors, Estrogen; Receptors, Metabotropic Glutamate; Signal Transduction; Tamoxifen; Transcriptome

2018